Abstract
Background and Objectives: Targeted drug is often engulfed and cleared by the reticuloendothelial system in vivo, resulting in reduced treatment efficacy. This study aimed to explore the biodistribution and HER-2-targeted antitumor effects of trastuzumab-modified gold nanorods (Tra-AuNRs) in a gastric cancer animal model.
Methods: Gold nanorods were synthesized using a seed-mediated growth method, and then subjected to trastuzumab-targeted modification. Elemental analysis, Fourier transform infrared spectroscopy, and Xray photoelectron spectroscopy were performed; UV-visible absorption peak, photothermal effects, morphology, and size distribution of Tra-AuNRs were characterized. The targeted killing effect of Tra- AuNRs on gastric cancer cells was assessed in vitro. Tra-AuNRs were injected intravenously and intratumorally into gastric cancer-bearing nude mice in vivo and their distribution was detected. Tumor growth inhibition rate and tumor apoptosis-related protein expression were compared between groups.
Results: Tra-AuNRs presented a relatively uniform morphology with an average particle size of 59.9 nm and a longitudinal plasmon resonance absorption peak of 790 nm. The targeted killing rate of gastric cancer cells in vitro by Tra-AuNRs was 87.9%. After intravenous injection, Tra-AuNRs were mainly distributed in the liver, tumor, spleen, and lungs. Comparatively, Tra-AuNRs were mainly distributed in the tumor when intratumorally injected, with a tumor concentration of 6.42 μg/g after 24 h. The tumor growth inhibition rate reached 78.3% in the intratumoral injection group, with significantly higher BAX, BAD, and CASPASE-3 expression than that in the intravenous injection group.
Conclusion: The findings suggest that Tra-AuNRs can be used for HER-2-positive gastric cancer treatment. Intratumoral injection of Tra-AuNRs significantly increased the local tumor drug concentration and improved the molecular targeted antitumor growth effect in gastric cancer-bearing nude mice.
Graphical Abstract
[http://dx.doi.org/10.7150/ntno.34921] [PMID: 31183314]
[http://dx.doi.org/10.1021/acs.analchem.9b02118] [PMID: 31403276]
[http://dx.doi.org/10.1016/j.heliyon.2021.e06923] [PMID: 34007921]
[http://dx.doi.org/10.1002/adma.200701972] [PMID: 18648528]
[http://dx.doi.org/10.1039/C2CS35367A] [PMID: 23128995]
[http://dx.doi.org/10.1007/s11307-016-0938-9] [PMID: 26884056]
[http://dx.doi.org/10.1166/jbn.2020.2876] [PMID: 31996286]
[http://dx.doi.org/10.1021/acsomega.9b01200] [PMID: 31497691]
[http://dx.doi.org/10.1038/cgt.2014.80] [PMID: 25613482]
[PMID: 29277796]
[http://dx.doi.org/10.1002/adma.201201690] [PMID: 22740090]
[http://dx.doi.org/10.7150/thno.4756] [PMID: 22916075]
[http://dx.doi.org/10.1021/acsnano.5b07172] [PMID: 26761620]
[http://dx.doi.org/10.1039/C6FD00145A] [PMID: 27442269]
[http://dx.doi.org/10.1021/nl304478h] [PMID: 23286198]
[http://dx.doi.org/10.1007/s00432-019-02866-7] [PMID: 30805775]
[http://dx.doi.org/10.3390/polym10020187] [PMID: 30966223]
[http://dx.doi.org/10.1021/ic0519382] [PMID: 16961339]
[http://dx.doi.org/10.1021/ja028110o] [PMID: 12452700]
[http://dx.doi.org/10.1016/j.ejpb.2010.11.010] [PMID: 21093587]
[http://dx.doi.org/10.1002/advs.201800382] [PMID: 30356957]
[http://dx.doi.org/10.1021/acs.bioconjchem.8b00522] [PMID: 30376632]
[http://dx.doi.org/10.1155/2017/6081724] [PMID: 29434531]
[http://dx.doi.org/10.1021/bc3004815] [PMID: 23631707]
[http://dx.doi.org/10.1038/nprot.2008.1] [PMID: 18274533]
[http://dx.doi.org/10.1016/j.ijpharm.2015.11.032] [PMID: 26608619]
[http://dx.doi.org/10.1007/s12032-010-9762-2] [PMID: 21136211]